Lexaria Bioscience (LEXX) Net Margin Growth (3y) (2020 - 2026)
Lexaria Bioscience (LEXX) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 50,811.00 |
| Aug 31, 2025 | 287,198.00 |
| May 31, 2025 | 457,360.00 |
| Feb 28, 2025 | -310,007.00 |
| Nov 30, 2024 | 1.58 Mn |
| Aug 31, 2024 | 641,677.00 |
| May 31, 2024 | 339,595.00 |
| Feb 29, 2024 | 62,426.00 |
| Nov 30, 2023 | 102,866.00 |
| Aug 31, 2023 | 502,090.00 |
| May 31, 2023 | 682,622.00 |
| Feb 28, 2023 | 902,283.00 |
| Nov 30, 2022 | 698,494.00 |
| Aug 31, 2022 | -45,849.00 |
| May 31, 2022 | -43,443.00 |
| Feb 28, 2022 | 1.21 Mn |
| Nov 30, 2021 | -1.12 Mn |
| Aug 31, 2021 | -252,410.00 |
| May 31, 2021 | 118,735.00 |
| Feb 28, 2021 | 59,111.00 |